FI934701A - Analyssystem foer maetning och/eller detektering av neurotrofinaktivitet - Google Patents

Analyssystem foer maetning och/eller detektering av neurotrofinaktivitet Download PDF

Info

Publication number
FI934701A
FI934701A FI934701A FI934701A FI934701A FI 934701 A FI934701 A FI 934701A FI 934701 A FI934701 A FI 934701A FI 934701 A FI934701 A FI 934701A FI 934701 A FI934701 A FI 934701A
Authority
FI
Finland
Prior art keywords
image
neurotrophinactivity
analysis
bdnf
trkb
Prior art date
Application number
FI934701A
Other languages
English (en)
Other versions
FI934701A0 (fi
Inventor
Stephen P Squinto
David Glass
Thomas H Aldrich
Peter Distephano
Trevor Stitt
Mark E Furth
George D Yancopoulos
Peter C Maisonpierre
Piotr Masiakowski
Nancy Ip
Original Assignee
Regeneron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regeneron Pharma filed Critical Regeneron Pharma
Publication of FI934701A0 publication Critical patent/FI934701A0/fi
Publication of FI934701A publication Critical patent/FI934701A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82—Translation products from oncogenes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475—Assays involving growth factors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Wood Science & Technology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Neurology (AREA)
  • Oncology (AREA)
  • Toxicology (AREA)
  • Neurosurgery (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Saccharide Compounds (AREA)
FI934701A 1991-04-23 1993-10-25 Analyssystem foer maetning och/eller detektering av neurotrofinaktivitet FI934701A (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US69019991A 1991-04-23 1991-04-23
US73655991A 1991-07-26 1991-07-26
PCT/US1992/003376 WO1992018149A1 (en) 1991-04-23 1992-04-23 Assay systems for neurotrophin activity

Publications (2)

Publication Number Publication Date
FI934701A0 FI934701A0 (fi) 1993-10-25
FI934701A true FI934701A (fi) 1993-12-22

Family

ID=27104557

Family Applications (1)

Application Number Title Priority Date Filing Date
FI934701A FI934701A (fi) 1991-04-23 1993-10-25 Analyssystem foer maetning och/eller detektering av neurotrofinaktivitet

Country Status (19)

Country Link
EP (2) EP1001024B1 (fi)
JP (1) JPH06509413A (fi)
AT (2) ATE336576T1 (fi)
AU (1) AU676664B2 (fi)
CA (1) CA2109100A1 (fi)
CZ (1) CZ223793A3 (fi)
DE (2) DE69232496T2 (fi)
DK (1) DK0589961T3 (fi)
ES (1) ES2170056T3 (fi)
FI (1) FI934701A (fi)
HK (1) HK1024935A1 (fi)
HU (1) HUT66051A (fi)
IE (1) IE921316A1 (fi)
IL (1) IL101661A (fi)
NO (1) NO933819L (fi)
NZ (1) NZ242468A (fi)
PT (1) PT100423A (fi)
SK (1) SK116593A3 (fi)
WO (1) WO1992018149A1 (fi)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ242813A (en) * 1991-05-21 1996-09-25 Regeneron Pharma Neurotrophin -4 (nt-4), its use as a pharmaceutical, diagnostic kits, chimeric preproproteins, vectors, recombinant nt-4
JPH07509600A (ja) * 1992-06-12 1995-10-26 リジェネロン　ファーマシューティカルズ，インコーポレーテッド ニューロトロフィン−４発現に基づく治療および診断法
JPH07246040A (ja) * 1993-07-06 1995-09-26 Takeda Chem Ind Ltd ニューロトロフィン−３遺伝子が不活性化された胚幹細胞および該遺伝子発現不全動物
US5625121A (en) * 1993-09-02 1997-04-29 Bristol-Myers Squibb Company Mice deficient in nerve growth factor receptors encoded by trkB
US5753225A (en) 1993-12-03 1998-05-19 The Regents Of The University Of California Antibodies that mimic actions of neurotrophins
US7196055B2 (en) 1994-08-31 2007-03-27 Trustees Of Boston University Inhibition of apoptosis in keratinocytes by a ligand of p75 nerve growth factor receptor
US6867179B1 (en) 1994-08-31 2005-03-15 Trustees Of Boston University Methods of inducing hair growth and coloration
US6103689A (en) * 1994-08-31 2000-08-15 Trustees Of Boston University Methods of inducing hair growth and coloration
CZ310798A3 (cs) * 1996-03-28 1999-02-17 Trustees Of Boston University Způsob tlumení aktivace tyrosinasy, upravování pigmentace a identifikace látky, látka zesilující fosforylaci tyrosinasy, látka tlumící fosforylaci tyrosinasy, použití činidla tlumícího fosforylaci tyrosinasy, použití peptidu a použití DNA
AU719038B2 (en) 1996-03-29 2000-05-04 Trustees Of Boston University Methods for diagnosing and treating Alzheimer's disease
GB9807781D0 (en) * 1998-04-09 1998-06-10 Univ Bristol Therapeutic agent
EP2789630A1 (en) 2013-04-09 2014-10-15 EngMab AG Bispecific antibodies against CD3e and ROR1
EP3204415B1 (en) 2014-10-09 2020-06-17 EngMab Sàrl Bispecific antibodies against cd3epsilon and ror1

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4963481A (en) * 1985-12-18 1990-10-16 Genetics Institute Inc Promoter system
US5231001A (en) * 1991-03-14 1993-07-27 The United States Of America As Represented By The Department Of Health And Human Services Trk tyrosine kinase receptor is the physiological receptor for nerve growth factor
CA2062377A1 (en) * 1991-03-21 1992-09-22 Mariano Barbacid Method for detection of neuroactive substances
US5843749A (en) * 1991-07-26 1998-12-01 Regeneron Pharmaceuticals, Inc. Ehk and Ror tyrosine kinases

Also Published As

Publication number Publication date
NO933819L (no) 1993-12-20
HU9303012D0 (en) 1994-03-28
CA2109100A1 (en) 1992-10-29
EP1001024A3 (en) 2004-02-18
AU676664B2 (en) 1997-03-20
PT100423A (pt) 1993-08-31
IL101661A (en) 1998-02-08
CZ223793A3 (en) 1994-08-17
HK1024935A1 (en) 2000-10-27
JPH06509413A (ja) 1994-10-20
DE69233649D1 (de) 2006-09-28
ATE214733T1 (de) 2002-04-15
DE69232496D1 (de) 2002-04-25
EP0589961A4 (en) 1994-11-02
DK0589961T3 (da) 2002-05-27
ATE336576T1 (de) 2006-09-15
IL101661A0 (en) 1992-12-30
FI934701A0 (fi) 1993-10-25
EP0589961B1 (en) 2002-03-20
IE921316A1 (en) 1992-11-04
WO1992018149A1 (en) 1992-10-29
AU2014992A (en) 1992-11-17
SK116593A3 (en) 1994-11-09
NO933819D0 (no) 1993-10-22
NZ242468A (en) 1994-12-22
EP1001024A2 (en) 2000-05-17
EP0589961A1 (en) 1994-04-06
EP1001024B1 (en) 2006-08-16
ES2170056T3 (es) 2002-08-01
HUT66051A (en) 1994-09-28
DE69232496T2 (de) 2002-10-10

Similar Documents

Publication Publication Date Title
FI934701A0 (fi) Analyssystem foer maetning och/eller detektering av neurotrofinaktivitet
Walz et al. Immunocytochemical evidence for a distinct GFAP-negative subpopulation of astrocytes in the adult rat hippocampus
DE69033067D1 (de) 4,7-dichlorfluoreszein-farbstoffe als molekulare sonden
ATE290594T1 (de) Vegf-c-rezeptorligand
DK0586595T3 (da) Prøveapparat
NO984355D0 (no) FremgangsmÕte for mÕling av en analytts konsentrasjon
DK0429612T3 (da) Fremgangsmåde til optisk analyse
DE3771185D1 (de) Optischer detektor zur gleichzeitigen erfassung von herzschlag und toraxbewegung.
DK0770876T3 (da) En screening-fremgangsmåde til at identificere ligander for målproteiner
DE3765138D1 (de) Mehrschichtiges element zur quantitativen analyse von immunoreagenzien.
DE69023476D1 (de) Mehrschicht-Testvorrichtung zur Bestimmung von Substanzen in Flüssigkeiten.
FR2396300A1 (fr) Dispositif pour le dosage unique de selles sur du papier reactif
BR0114514A (pt) Método de medição de secura de polpa, método e sistema de controle de descarga de polpa e suco e método de controle de concentração de polpa
DE69005370D1 (de) Membranmessfühler mit Konzentration von Deformationen.
ATE143142T1 (de) Immunoassay zum nachweis von antikörpern gegen hiv
FR2655835B1 (fr) Appareil de detection de kystes et/ou tumeurs du sein.
DE69202855D1 (de) Vorrichtung zur trockenen chemischen analyse von flüssigkeiten.
DE69434498D1 (de) Denervierende muskelkinase (dmk), ein rezeptor der tyrosinkinase-superfamilie
ES2184109T3 (es) Determinacion de analitos mediando utilizacion de dos marcaciones.
Derogis et al. Breath alcohol versus blood alcohol. 204 Cases in an emergency unit.
ITO et al. Direct analysis of Glu-plasminogen and Lys-plasminogen in human plasma with high-performance affinity chromatography (2)
Munck et al. Glucagon-related peptides in human bowel: Quantitative evaluation by HPLC-radioreceptorassay. Evidence for the presence of glucagon-371 (oxyntomodulin2/bioactive enteroglucagon) and glucagon-29 (pancreatic glucagon)
IT8968017A0 (it) Sistema di controllo e gestione delle prove di qualita' ed affidabilita' di componenti fisici e/o gruppi di componenti fisici, e relativi mezzi per la sua attuazione
RU95111009A (ru) Способ выявления сенсибилизации к лекарственным аллергенам
WO2000033073A3 (de) Detektionsverfahren für no im vollblut von säugern

Legal Events

Date Code Title Description
FD Application lapsed